Compare PLBC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLBC | SOPH |
|---|---|---|
| Founded | 1980 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.9M | 330.4M |
| IPO Year | 2005 | 2021 |
| Metric | PLBC | SOPH |
|---|---|---|
| Price | $45.52 | $4.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $55.00 | $7.00 |
| AVG Volume (30 Days) | 17.9K | ★ 105.6K |
| Earning Date | 01-14-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $89,868,000.00 | $73,297,000.00 |
| Revenue This Year | $21.11 | $18.32 |
| Revenue Next Year | $16.11 | $15.61 |
| P/E Ratio | $10.77 | ★ N/A |
| Revenue Growth | 12.51 | ★ 13.66 |
| 52 Week Low | $38.71 | $2.58 |
| 52 Week High | $49.63 | $5.30 |
| Indicator | PLBC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 71.08 | 52.09 |
| Support Level | $43.50 | $4.54 |
| Resistance Level | $45.71 | $4.84 |
| Average True Range (ATR) | 0.80 | 0.30 |
| MACD | 0.25 | -0.02 |
| Stochastic Oscillator | 95.70 | 39.25 |
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.